Novartis Approvals Dominate Rx-To-OTC Switches In 1999
This article was originally published in The Tan Sheet
Executive Summary
Novartis Consumer Health cornered the Rx-to-OTC switch landscape in 1999, receiving approval for and bringing to market former Rx drugs Lamisil AT and Habitrol.